» LEARN MORE ABOUT COVID-19 VACCINES, TESTING, VISITOR & SAFETY REQUIREMENTS

MyHealth

Manage your account, request prescriptions, set up appointments & more.

LOG IN
Don't have an account
Contact Us
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label
    • see more mega-menu-label

COG-AALL08B1

Trial

Clinical Trial Title

Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Trial Status

Open to Enrollment

Start Date

August 17, 2010

Trial Type

Pediatric Cancer (Oncology)

Specific Condition

Acute Lymphoblastic Leukemia (ALL)

Description

This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.

Eligibility Criteria

Patients must be enrolled on AALL08B1 prior to enrollment on a COG ALL therapeutic study

A bone marrow examination is required, unless there is a medical contraindication to having the test performed

Newly diagnosed acute leukemia: >25% blast on a BM aspirate (OR by pathologic diagnosis of acute leukemia on a bone marrow biopsy, OR a complete blood count documenting the presence of at least 1,000/uL circulating leukemic blasts)

Age: <31 years of age at diagnosis of acute leukemia

Principal Investigator Name

Janice Olson, MD

Contact Name

Children's Cancer and Blood Disorders Program

Phone

(503) 276-9300

Last Updated: Wednesday, January 27, 2021 11:41:04 AM